-+ 0.00%
-+ 0.00%
-+ 0.00%

Avalo Therapeutics shareholders approved amended employee stock purchase plan at annual meeting

PUBT·06/08/2026 20:20:12
Listen to the news
Avalo Therapeutics shareholders approved amended employee stock purchase plan at annual meeting
  • Avalo Therapeutics held its annual shareholder meeting on June 2, 2026.
  • Shareholders backed amendments to the company’s 2016 employee stock purchase plan, clearing the updated plan for implementation.
  • Shareholders also ratified Ernst & Young as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001534120-26-000036), on June 08, 2026, and is solely responsible for the information contained therein.